Literature DB >> 2750976

Abnormal melatonin response to 5-methoxypsoralen in dementia.

E Souêtre1, E Salvati, B Krebs, J L Belugou, G Darcourt.   

Abstract

The authors investigated the melatonin response to 5-methoxypsoralen in 39 healthy adult and elderly subjects and in 13 demented, 13 depressed, and 13 schizophrenic inpatients. Subjects' plasma melatonin levels were evaluated before they took single, oral 40-mg doses of 5-methoxypsoralen and 3 hours afterward. The preliminary results indicate that the melatonin response of the pineal gland to 5-methoxypsoralen is reduced in demented patients compared to that in healthy elderly subjects. Depressed and schizophrenic patients had a normal melatonin response to the drug. This finding suggests that the pineal gland may be functionally impaired in dementia but not in depression.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2750976     DOI: 10.1176/ajp.146.8.1037

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  5 in total

1.  Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide.

Authors:  M A Pappolla; M Sos; R A Omar; R J Bick; D L Hickson-Bick; R J Reiter; S Efthimiopoulos; N K Robakis
Journal:  J Neurosci       Date:  1997-03-01       Impact factor: 6.167

2.  Anti-amyloidogenic and anti-apoptotic role of melatonin in Alzheimer disease.

Authors:  Hongwen He; Weiguo Dong; Fang Huang
Journal:  Curr Neuropharmacol       Date:  2010-09       Impact factor: 7.363

3.  Pro: Alzheimer's disease and circadian dysfunction: chicken or egg?

Authors:  Tracy A Bedrosian; Randy J Nelson
Journal:  Alzheimers Res Ther       Date:  2012-08-13       Impact factor: 6.982

Review 4.  Melatonin levels in the Alzheimer's disease continuum: a systematic review.

Authors:  Sebastiaan Engelborghs; Ilse Smolders; Amber Nous
Journal:  Alzheimers Res Ther       Date:  2021-02-23       Impact factor: 6.982

5.  Serum Daytime Melatonin Levels Reflect Cerebrospinal Fluid Melatonin Levels in Alzheimer's Disease but Are Not Correlated with Cognitive Decline.

Authors:  Amber Nous; Mandy Melissa Jane Wittens; Yannick Vermeiren; Peter Paul De Deyn; Christine Van Broeckhoven; Guy Nagels; Ilse Smolders; Sebastiaan Engelborghs
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.